Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Annovis Bio, Inc.

http://annovisbio.com

Latest From Annovis Bio, Inc.

RealView Receives FDA Nod For Holographic System Allowing Physicians To ‘Hold’ Floating Organ

Israeli-based start-up RealView received US FDA 510(k) clearance for its Holoscope-i holographic system used prior to and during interventional procedures.

FDA Approvals

Handheld Ultrasound Developer Exo Raised $220M In Series C

As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date. 

Financing Diagnostic Imaging

Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

Local Medicare carrier Novitas raised its reimbursement rates for continuous cardiac monitoring, but iRhythm has concluded the rates are still too low and is preparing to discontinue serving this Medicare segment.

Reimbursement Cardiovascular

Annovis’s Novel Approach To Parkinson’s Shows Early Promise

Micro-cap Annovis Bio’s lead candidate has shown promise in nine patients with Parkinson’s, and could move into late-stage studies this year.

BioPharmaceutical Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • QR Pharma, Inc.
UsernamePublicRestriction

Register